Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Sun, Lova, Aggarwal, Charu, Cohen, Roger B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352329/
https://www.ncbi.nlm.nih.gov/pubmed/34396182
http://dx.doi.org/10.1016/j.jaccao.2019.11.014
_version_ 1783736155807678464
author Sun, Lova
Aggarwal, Charu
Cohen, Roger B.
author_facet Sun, Lova
Aggarwal, Charu
Cohen, Roger B.
author_sort Sun, Lova
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-8352329
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-83523292021-08-13 Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated? Sun, Lova Aggarwal, Charu Cohen, Roger B. JACC CardioOncol Original Research [Figure: see text] Elsevier 2019-12-17 /pmc/articles/PMC8352329/ /pubmed/34396182 http://dx.doi.org/10.1016/j.jaccao.2019.11.014 Text en © 2019 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Sun, Lova
Aggarwal, Charu
Cohen, Roger B.
Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?
title Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?
title_full Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?
title_fullStr Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?
title_full_unstemmed Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?
title_short Immune Checkpoint Inhibitor–Related Cardiovascular Toxicity in Lung Cancer: Is Routine Screening Indicated?
title_sort immune checkpoint inhibitor–related cardiovascular toxicity in lung cancer: is routine screening indicated?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352329/
https://www.ncbi.nlm.nih.gov/pubmed/34396182
http://dx.doi.org/10.1016/j.jaccao.2019.11.014
work_keys_str_mv AT sunlova immunecheckpointinhibitorrelatedcardiovasculartoxicityinlungcancerisroutinescreeningindicated
AT aggarwalcharu immunecheckpointinhibitorrelatedcardiovasculartoxicityinlungcancerisroutinescreeningindicated
AT cohenrogerb immunecheckpointinhibitorrelatedcardiovasculartoxicityinlungcancerisroutinescreeningindicated

Ejemplares similares